TRIB 0.93 (-7%)
US8964383066Medical Diagnostics & ResearchDiagnostics & Research

Trinity Biotech (TRIB) Competitor Comparison

We are evaluating the key criteria listed to compare Trinity Biotech (TRIB) against its competitors in the Diagnostics & Research industry.

Performance 5 years - TRIB ranking 48 / 58

These are the competitors of Trinity Biotech in the industry Diagnostics & Research ranked by performance 5 years
1. Natera NTRA
370.27
2. Medpace Holdings MEDP
349.8
3. Lantheus Holdings LNTH
340.53
4. RadNet RDNT
306.57
5. Meridian Bioscience VIVO
118.46
6. Twist Bioscience TWST
115.27
7. Danaher DHR
75.73
8. IDEXX Laboratories IDXX
71.59
9. Agilent Technologies A
70.94
10. Waters WAT
70.3
11. Mettler-Toledo MTD
68.78
12. Thermo Fisher Scientific TMO
66.13
13. Fulgent Genetics FLGT
65.41
14. DarioHealth DRIO
61.4
15. Laboratory Corp of America Holdings LH
57.13
16. PerkinElmer PKI
48.44
17. Quest Diagnostics DGX
47.4
18. IQVIA Holdings IQV
38.48
19. DexCom DXCM
36.11
20. Icon ICLR
34.16
21. Charles River Laboratories CRL
31.36
22. CareDx CDNA
20.61
23. Ortho Clinical Diagnostics Holdings OCDX
13.74
24. Heska HSKA
12.14
25. Co-Diagnostics CODX
6.45
26. Qiagen QGEN
2.92
27. Inotiv NOTV
-11.69
28. Anixa Biosciences ANIX
-14.51
29. Syneos Health SYNH
-16.98
30. Bioventus BVS
-22.91
31. Exact Sciences EXAS
-25.66
32. Olink Holding OLK
-26.82
33. NeoGenomics NEO
-33.88
34. Myriad Genetics MYGN
-36.83
35. Interpace Biosciences IDXG
-37.31
36. Guardant Health GH
-50.73
37. Sotera Health SHC
-51.93
38. Illumina ILMN
-54.82
39. Personalis PSNL
-54.86
40. Sera Prognostics SERA
-57.63
41. Pacific Biosciences of California PACB
-61.7
42. Neogen NEOG
-63.5
43. Enzo Biochem ENZ
-65.26
44. National Research NRC
-69.95
45. Psychemedics PMD
-73.47
46. Exagen XGN
-74.8
47. MaxCyte MXCT
-78.4
48. Trinity Biotech TRIB
-80.93
49. MDxHealth MDXH
-83.54
50. Global Cord Blood CO
-86.47
51. Precipio PRPO
-86.54
52. bioAffinity Technologies BIAF
-87.5
53. Biodesix BDSX
-90.07
54. Neuronetics STIM
-92.42
55. Aspira Womens Health AWH
-92.98
56. Organovo Holdings ONVO
-95.1
57. SeqLL SQL
-95.22
58. Prenetics Global PRE
-96.32

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.